WHO restricts Ervebo use in Bundibugyo outbreak
<img width="1024" height="678" src="https://i0.wp.com/media.premiumtimesng.com/wp-content/files/2026/08/World-Health-Organisation.jpg?fit=1024%2C678&ssl=1" class="webfeedsFeaturedVisual wp-post-image" alt="World Health Organisation (WHO)" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" srcset="https://i0.wp.com/media.premiumtimesng.com/wp-content/files/2026/08/World-Health-Organisation.jpg?w=1024&ssl=1 1024w, https://i0.wp.com/media.premiumtimesng.com/wp-content/files/2026/08/World-Health-Organisation.jpg?resize=526%2C349&ssl=1 526w, https://i0.wp.com/media.premiumtimesng.com/wp-content/files/2026/08/World-Health-Organisation.jpg?resize=768%2C509&ssl=1 768w, https://i0.wp.com/media.premiumtimesng.com/wp-content/files/2026/08/World-Health-Organisation.jpg?resize=750%2C497&ssl=1 750w" sizes="(max-width: 1024px) 100vw, 1024px" /><p>WHO said Ervebo should currently be used against Bundibugyo virus only within a research protocol to generate evidence on its effectiveness, rather than through broader routine outbreak vaccination.</p> <p>The post <a href="https://www.premiumtimesng.com/health/health-news/906969-who-restricts-ervebo-use-in-bundibugyo-outbreak.html">WHO restricts Ervebo use in Bundibugyo outbreak</a> appeared first on <a href="https://www.premiumtimesng.com">Premium Times Nigeria</a>.</p>